New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Heatwurx Inc.

PCSA

Healthcare Biotechnology

EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.67 0.03 −1.76%
Market cap
$4.8M
P/E
n/m
Fwd P/E FY16e
—
Dividend yield
—
F-score
n/a
ROIC
0.00%
Net debt / EBITDA
0.4×
Payout ratio
—

What it owns vs. what it owes Q3 FY2026, 30 September 2026

Liabilities are $181.4M more than assets: shareholders’ equity is negative. What is a balance sheet?

30 September 2026 · total $182.0M

Owns

$3.0KLong-term assets
$1.8MOther short-term assets
$180.2MCash & short-term investments

Funded by

$363.4MOther liabilities

Debt is 0.0% of the total; liabilities are $181.4M more than assets.

Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Cash and Short Term Investments
180.21 0.20 1.69 5.54

+8 more quarters

Other current assets
0.43 0.47 — —
Total current assets
182.01 2.07 1.94 5.67
Property, Plant, Equpment (Net)
0.00 0.00 0.00 0.00
Goodwill and Intangible Assets (Total)
— — 1.59 1.15
Long-term assets (Other)
— — 0.99 0.99
Total non-current assets
0.00 0.00 2.58 2.14
Total Assets
182.01 2.07 4.52 7.81
Accounts Payable
1.19 1.66 0.84 1.06
Accrued Expenses
0.67 0.73 1.14 1.18
Total current liabilities
1.86 2.39 1.98 2.24
Liabilities (Preferred Stock)
361.53 — — —
Total non-current liabilities
361.53 — — —
Total liabilities
363.40 2.39 1.98 2.24
Additional Paid In Capital
109.22 107.11 106.70 106.66
Common Stock (Net)
— 0.00 0.00 0.00
Retained Earnings
(290.58) (107.43) (104.16) (100.78)
Treasury Stock
— — — 0.30
Common Equity (Total)
(181.38) (0.32) 2.54 5.58
Shareholders Equity (Total)
(181.38) (0.32) 2.54 5.58
Shareholders Equity and Liabilities (Total)
182.01 2.07 4.52 7.81
Shares (Common)
2.80 2.79 2.68 2.57
Shareholders Equity (Tangible)
(181.38) (0.32) 0.96 4.43
Net Debt
(180.20) (0.20) (1.69) (5.54)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 18 Nov 2026